conclusion:
  outcome: 18 months
  explanation: In the given case, the patient is diagnosed with stage II colon adenocarcinoma, which is an earlier stage compared to the examples provided. The tumor exhibits moderately differentiated differentiation histology, which is generally associated with a better prognosis than poorly differentiated histology. Additionally, there are no signs of carcinomatosis, which is a positive factor for the patient's prognosis. Under an optimal standard of care treatment plan, the patient is expected to have a longer progression-free survival than the examples provided. Considering the age and stage of the disease, an estimated progression-free survival of 18 months is reasonable. However, it is important to note that individual responses to treatment may vary, and this estimate is based on the limited information provided.